投资者调整了对Abbott和AbbVie的股权,这两家公司都报告了丰厚的收益和股息。 Investors adjust stakes in Abbott and AbbVie, both of which reported strong earnings and dividends.

一些机构投资者最近调整了在保健公司Abbott实验室和AbbVie Inc.Harel保险投资公司的股权,购买了1 458份Abbott股份,总股份为2 451份,价值325 000美元。 Several institutional investors have recently adjusted their stakes in healthcare companies Abbott Laboratories and AbbVie Inc. Harel Insurance Investments bought 1,458 shares of Abbott, bringing its total to 2,451 shares, valued at $325,000. Novare资本管理公司将其在Abbott的股份减少了1.9%,同时投资顾问将其在AbbVie的股份增加了26.5%,现在拥有93 773个股份。 Novare Capital Management reduced its holdings in Abbott by 1.9%, while Concurrent Investment Advisors increased its holdings in AbbVie by 26.5%, now owning 93,773 shares. 两家公司都报告收入丰厚,Abbott公司超过预期,宣布季度股息为0.59美元。 Both companies reported strong earnings, with Abbott exceeding expectations and declaring a $0.59 quarterly dividend. AbbVie也超过了收入估计数,并宣布季度红利为1.64美元。 AbbVie also surpassed earnings estimates and announced a $1.64 quarterly dividend.